A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control

AIM: To evaluate the efficacy and safety of adding the once‐weekly oral dipeptidyl peptidase‐4 inhibitor omarigliptin to treatment of Japanese patients with type 2 diabetes and inadequate glycaemic control on insulin monotherapy. MATERIALS AND METHODS: In a 52‐week clinical trial, Japanese patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadowaki, Takashi, Seino, Yutaka, Kaku, Kohei, Okamoto, Taro, Kameya, Miho, Sato, Asako, Hirano, Tomona, Oshima, Nobuyuki, Gantz, Ira, O'Neill, Edward A., Engel, Samuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248035/
https://www.ncbi.nlm.nih.gov/pubmed/33512755
http://dx.doi.org/10.1111/dom.14331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248035/
https://www.ncbi.nlm.nih.gov/pubmed/33512755
http://dx.doi.org/10.1111/dom.14331

Ejemplares similares